PARNAX LAB LTD. Share Price

₹ 116.00

+₹2.59 (2.28%)
1D
Last updated 20 Nov, 2026, 15:27 IST
NSE: PARNAXLAB
|
Pharmaceuticals

PARNAX LAB LTD. Share Price Today

As of 22 Nov 2026, PARNAX LAB LTD. share price is ₹116.00. The stock opened at ₹113.41, compared to its previous close of ₹113.41. During today's trading session, PARNAX LAB LTD. share price moved in the range of ₹109.00 to ₹116.50, with an average price of ₹112.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹90.00 and a high of ₹149.50. On the performance front, PARNAX LAB LTD. share price has declined by 15.25% over the last six months and is down 15.25% on a year-on-year basis.

Share price over the last 1 day fell from 116.99 to 116.00, ranging between 110.82 and 116.99.

₹109.00
2.28% up today
₹116.50
1D LOW
1D HIGH

PARNAX LAB LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 430.00% QoQ
Latest Earning
Net Profit TrendUp by 406.98% QoQ
Latest Earning
Revenue TrendUp by 21.98% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 3.38 % in last 1 yr
PARNAX LAB LTD. stock performance
Open₹113.41
High₹116.50
Low₹109.00
Prev. close₹113.41
PARNAX LAB LTD. trading activity
Volume1,538
Average traded price₹115.42
Last traded time03:27:53 20 Nov
Last traded quantity54

Circuit
L
H
₹91.90
₹137.84
52-week
L
H
₹90.00
₹149.50
Mkt Cap Cr
133.12

P/E
17.72

P/B
1.36

ROA
3.01%
ROE
8.77%

ROCE
9.9%

Quick Ratio
0.57

EV/EBITDA
8.48

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Parnax Lab outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Parnax Lab appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Parnax Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.67
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.03
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.58
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.59
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.48
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PARNAX LAB LTD. Company Background

ISIN
INE383L01019
Sector Market Cap
₹ 133.12 Cr

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.

PARNAX LAB LTD. Financial Highlights

  • Revenue: PARNAX LAB LTD. reported revenue of ₹252.32 crore in FY26 vs ₹189.42 crore in FY25. It showed an increase of 33.21% on a yearly basis.
  • Operating Profit: PARNAX LAB LTD. reported an operating profit of ₹15.91 crore in FY26 vs ₹15.67 crore in FY25. It showed an increase of 1.53% on a year-on-year basis.
  • Net Profit: PARNAX LAB LTD. reported a net profit of ₹11.80 crore in FY26 vs ₹11.54 crore in FY25. It showed an increase of 2.25% on a yearly basis.

PARNAX LAB LTD. Quarterly Result Highlights

  • PARNAX LAB LTD. reported revenue of ₹69.47 crore in Sep 2026, compared with ₹56.95 crore in Jun 2026, representing an increase of 21.98% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported an operating profit of ₹3.18 crore in Sep 2026, compared with ₹0.60 crore in Jun 2026, representing an increase of 430.00% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported a profit of ₹2.18 crore in Sep 2026, compared with ₹0.43 crore in Jun 2026, reflecting an increase of 406.98% on a QoQ basis.
  • The earnings per share (EPS) of PARNAX LAB LTD. stood at ₹10.27 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.30%
FII
0.00%
Other DII
0.00%
Retail and other
27.70%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

PARNAX LAB LTD. Investment Returns

1 day
+1.29%

1 week
+6.36%

1 month
+5.41%

1 year
-15.25%

3 years
-15.25%

5 years
-15.25%

PARNAX LAB LTD. Share Price History

PARNAX LAB LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹113.41 / ₹114.87
+1.29%
19 Nov 26
₹119.00 / ₹113.41
-2.59%
18 Nov 26
₹114.52 / ₹116.42
+1.66%
17 Nov 26
₹109.00 / ₹114.52
+5.94%
Show more

PARNAX LAB LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹248.54₹187.74₹188.71₹167.61
Other Income₹3.78₹1.68₹0.82₹0.77
Total Revenue₹252.33₹189.41₹189.53₹168.38
Total Expenses₹235.05₹173.74₹177.48₹156.10
Profit Before Tax₹15.91₹15.67₹12.05₹12.28
Tax₹4.11₹4.14₹2.42₹3.65
Profit After Tax₹11.80₹11.54₹9.62₹8.63
EPS - Basic₹10.27₹10.05₹8.37₹7.80
EPS - Diluted₹10.27₹10.05₹8.37₹7.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹15.91₹15.67₹12.05₹12.28
Income before WC changes₹30.47₹28.51₹23.91₹23.86
Change in Assets-₹31.10₹8.14-₹13.07₹9.27
Change in Liabilities₹12.14-₹1.61₹7.67-₹9.35
Change in WC-₹18.95₹6.53-₹5.40-₹0.09
Cash flow from Operations₹8.00₹32.30₹15.88₹20.91
Cash flow from Investing-₹16.39-₹16.39-₹31.52-₹9.92
Cash flow from Financing₹8.18-₹15.82₹14.82-₹14.07
Total Cash Flow-₹0.21₹0.09-₹0.82-₹3.08
Cash (Start of the year)₹0.55₹0.46₹1.28₹4.36
Cash (End of the year)₹0.34₹0.55₹0.46₹1.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹136.94₹125.04₹116.95₹87.75
Current Assets₹90.69₹64.78₹73.31₹57.32
Total Assets₹227.63₹189.82₹190.26₹145.07
Current Liabilities₹95.85₹74.33₹83.33₹63.04
Net Current Asset-₹5.16-₹9.56-₹10.02-₹5.72
Non-Current Liabilities₹36.48₹32.24₹35.24₹19.77
Equity Capital₹95.30₹83.24₹71.69₹62.26
Total Equity & Liabilities₹227.63₹189.82₹190.26₹145.07

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6.63₹7.02₹7.44₹7.47
Other Income₹2.37₹0.71₹0.54₹0.37
Total Revenue₹8.99₹7.73₹7.98₹7.84
Total Expenses₹8.31₹5.87₹5.53₹6.22
Profit Before Tax₹0.65₹1.86₹2.45₹1.63
Tax-₹0.24₹0.46₹0.62₹0.42
Profit After Tax₹0.89₹1.39₹1.82₹1.20
EPS - Basic₹0.77₹1.21₹1.59₹1.09
EPS - Diluted₹0.77₹1.21₹1.59₹1.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.65₹1.86₹2.45₹1.63
Income before WC changes₹1.35₹1.44₹2.34₹1.80
Change in Assets-₹1.30-₹1.81-₹2.35-₹1.34
Change in Liabilities-₹0.76₹0.68₹0.11-₹0.73
Change in WC-₹2.06-₹1.14-₹2.24-₹2.07
Cash flow from Operations-₹0.72₹0.28₹0.08-₹0.28
Cash flow from Investing₹0.57-₹0.19₹0.30₹0.14
Cash flow from Financing-₹0.03-₹0.02-₹1.21-₹2.92
Total Cash Flow-₹0.18₹0.06-₹0.83-₹3.07
Cash (Start of the year)₹0.50₹0.44₹1.27₹4.33
Cash (End of the year)₹0.32₹0.50₹0.44₹1.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹12.78₹14.02₹14.20₹14.87
Current Assets₹11.82₹10.69₹8.04₹6.50
Total Assets₹24.60₹24.72₹22.24₹21.37
Current Liabilities₹1.00₹1.74₹1.06₹1.84
Net Current Asset₹10.83₹8.96₹6.98₹4.65
Non-Current Liabilities₹0.19₹0.43₹0.02₹0.17
Equity Capital₹23.42₹22.54₹21.15₹19.35
Total Equity & Liabilities₹24.60₹24.72₹22.24₹21.37
* All values are in INR Crore
PARNAX LAB LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
PARNAX LAB LTD. technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
56.66
Neutral

ATR (14)
8.94
Neutral

STOCH(9,6)
57.45
Neutral

STOCH RSI (14)
84.81
Bearish

ADX(9)
30.77
Bearish

UO(9)
44.59
Neutral

ROC(12)
9.96
Bullish

WillR(14)
-35.4
Neutral
Period
Simple value
Exponential vaue

5D
113.46
113.39

10D
111.02
111.51

20D
108.09
110.19

50D
113.1
109.47

100D
116.94
0
Volume trend — traded volume by day
20 Nov0L
19 Nov0L
18 Nov0L
17 Nov0L
16 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

PARNAX LAB LTD.
Pharmaceuticals
Add Stock
Add Another

PARNAX LAB LTD. Returns Calculator

PARNAX LAB LTD. Share Price FAQs












Please be aware that PARNAX LAB LTD. stock prices are subject to continuous fluctuations due to various factors.